Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion type Assertion NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_head.
- NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion wasGeneratedBy ECO_0000203 NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_provenance.
- NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion wasDerivedFrom befree-2016 NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_provenance.
- NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion SIO_000772 16916543 NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_provenance.
- NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion evidence source_evidence_literature NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_provenance.
- NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_assertion description "[BCR/ABL-positive acute myeloid leukemia (AML) is a rare disease, characterized by a poor prognosis, with resistance to induction chemotherapy and frequent relapses in responsive patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564747.RA4rwRfyNYRbKcNxeI6hHfjc9CrMeX3kmHTJ7Kp1SZvj0130_provenance.